Skip to main content
TipRanks
Go Ultimate75% OFF

National Health Investors (WX6) AI Stock Analysis

0 Followers
DE:WX6

National Health Investors

(Frankfurt:WX6)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring contractual rentLong-term healthcare leases provide recurring contractual rental income and greater visibility than transaction-dependent revenue. This model can support predictable cash generation and dividend capacity while periodic escalators offer a mechanism for rent growth over the medium term.
Negative Factors
SHOP occupancy executionSlower occupancy growth weakens the near-term operating contribution from SHOP investments and delays the realization of management's growth thesis. Continued transition disruption or underperformance at legacy communities could pressure NOI and require further operational intervention.

National Health Investors (WX6) vs. iShares MSCI Germany ETF (EWG)

-15%-10%-5%0%5%10%15%20%DE:WX6-12.87%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 3.09B
Dividend Yield
5.79%
Average Volume (3M)
235
Price to Earnings (P/E)
4.4
Beta (1Y)
0.05
Revenue Growth
21.66%
EPS Growth
326.52%
Country
Germany
Employees
32
Sector
Real Estate
Sector Strength
65
Industry
REIT - Healthcare Facilities

National Health Investors Business Overview & Revenue Model

Company Description

Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse f...

National Health Investors Earnings Call Summary

Earnings Call Date:Nov 09, 2026(Q3-2026)|% Change Since:-12.60%|Next Earnings Date:Feb 23, 2027
Earnings Call SentimentPositive

The call was broadly positive on NHI's strategic repositioning, investment pipeline, balance sheet, liquidity and long-term SHOP opportunity. However, management acknowledged that third-quarter SHOP performance was below expectations, occupancy growth was slower than anticipated, recurring and unbudgeted CapEx increased, and full-year FAD and NFFO guidance was reduced. The number and significance of the strategic and operating positives outweighed the identified execution challenges.

Positive Updates

Strategic Repositioning Toward Private-Pay Senior Housing
NHI completed the sale of the NHC portfolio on July 1, substantially reduced its skilled nursing exposure, and accelerated investment in private-pay senior housing and SHOP. Management said its conviction in SHOP remains strong and that the strategy is intended to enhance the company's growth profile and portfolio valuation potential.

Negative Updates

SHOP Performance Fell Short of Expectations
Management said third-quarter SHOP performance fell short of expectations. Although the 15 same-store properties delivered approximately 19.5% year-over-year NOI growth, performance in non-same-store communities reduced the total portfolio contribution expected for the quarter.

Company Guidance

Management expects to recycle more than 95% of the $555 million in NHC sale proceeds before year-end, with approximately $190 million of signed-LOI investments expected to close during the fourth quarter, bringing total 2026 investment to approximately $590 million; it expects 2026 to be its second largest investment year in the company's history, with low to mid-teens unlevered IRRs. The company continues to expect high single-digit to low double-digit organic NOI growth and an objective of high single-digit to low double-digit organic SHOP NOI growth, expects properties acquired before year-end to convert to SHOP in 2027, and expects occupancy to taper as it moves through the holiday season. Revised full year guidance is $4.68 to $4.70 per share for both NAREIT and normalized NFFO and $236.6 million to $237.7 million for funds available for distribution, including approximately $2.3 million in reduced SHOP NOI and increased recurring CapEx of approximately $2.8 million; the company does not expect a special dividend will be required for federal income tax purposes.

National Health Investors Risk Analysis

National Health Investors disclosed 43 risk factors in its most recent earnings report. National Health Investors reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

National Health Investors Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

DE:WX6 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
OHIOHI83Outperform$14.32B18.6014.32%5.74%13.90%37.56%
CTRECTRE77Outperform$9.81B23.648.10%3.95%43.65%17.90%
LTCLTC75Outperform$2.43B4.4639.59%5.27%68.94%1200.88%
SBRASBRA72Outperform$5.35B73.002.55%5.87%21.20%-61.51%
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
STRWSTRW56Neutral$691.79M55.9125.32%5.37%10.13%-63.21%

* Real Estate Sector Average

Performance Comparison

-10%0%10%20%30%DE:WX6LTCOHISBRACTRESTRWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:WX6 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:WX6National Health Investors55.50-7.25-11.55%
LTCLtc Properties43.289.2927.31%
OHIOmega Healthcare Investors47.055.3112.71%
SBRASabra Healthcare Reit20.442.9116.62%
CTRECareTrust REIT38.073.128.92%
STRWStrawberry Fields REIT Inc12.301.119.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.